BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking ...
Read More
Four key facts ahead of tomorrow’s drug pricing hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of ...
Read More
House members seek to block new wildlife refuge rules regarding GE crops
Members of Congress discussed legislation to block proposed federal rules that would regulate ...
Read More
House hearing delves into antitrust problems of PBMs
Market concentration allows pharmacy benefit managers (PBMs) to siphon off funds from our ...
Read More
New survey checks pulse on voters’ concerns for innovation and biomanufacturing
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to ...
Read More
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward
“The world of biotechnology is in the midst of a wave of exciting ...
Read More
EDITORS' CHOICE
New survey checks pulse on voters’ concerns for innovation and biomanufacturing
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the Biotechnology ...
September 14, 2024
Read More
LATEST NEWS
BIO's View
BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing on ...
September 18, 2024
BIO's View
Four key facts ahead of tomorrow’s drug pricing hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric about ...
September 16, 2024
Agriculture
House members seek to block new wildlife refuge rules regarding GE crops
Members of Congress discussed legislation to block proposed federal rules that would regulate growth of genetically engineered crops on wildlife refuges during a Sept. 10 ...
September 16, 2024
Federal Policy
House hearing delves into antitrust problems of PBMs
Market concentration allows pharmacy benefit managers (PBMs) to siphon off funds from our health care system while increasing costs to patients and reducing access to ...
September 16, 2024
BIO's View
New survey checks pulse on voters’ concerns for innovation and biomanufacturing
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the Biotechnology ...
September 14, 2024
HEALTH
House hearing delves into antitrust problems of PBMs
September 16, 2024
I am BIO Podcast: How Dr. David Fajgenbaum saved his own life
September 10, 2024
BIO at the World AMR Congress: ‘We know we’re racing against time’
September 10, 2024
What to know about Valley fever vaccine development
September 9, 2024
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
House members seek to block new wildlife refuge rules regarding GE crops
September 16, 2024
What to know about Valley fever vaccine development
September 9, 2024
USDA testing vaccine to protect cows from bird flu
September 2, 2024
USDA approves genetic trait that helps wheat handle drought
August 30, 2024
Climate Change
What to know about Valley fever vaccine development
September 9, 2024
As authorities reveal 19 people at a California music festival contracted Valley fever, a company making a Valley fever vaccine ...
Read More
Federal Policy
Four key facts ahead of tomorrow’s drug pricing hearing
September 16, 2024
House members seek to block new wildlife refuge rules regarding GE crops
September 16, 2024
House hearing delves into antitrust problems of PBMs
September 16, 2024
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward
September 13, 2024
State Policy
Innovative payment arrangements bring transformative therapies from the lab to patients
August 19, 2024
In recent years, the number of disruptive, cutting-edge therapies approved or under review by the Food and Drug Administration (FDA) ...
Read More
International
Bio's View
BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
September 18, 2024
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he ...
Read More
Four key facts ahead of tomorrow’s drug pricing hearing
September 16, 2024
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward
September 13, 2024